Jacques Bergman

Jacques Bergman was born in 1965 and qualified from the University of Utrecht in 1991. He undertook his PhD-training, dedicated to the endoscopic management of gallstone disease, in Amsterdam. He was trained in Gastroenterology in Den Bosch and Amsterdam and was appointed Consultant Gastroenterologist, at Academic Medical Center in Amsterdam in 2001 and as Associate Professor in 2005. In 2011 he appointed as Head of department of Endoscopy and Professor of Gastrointestinal Endoscopy.

Jacques Bergman has served on the Editorial Boards of “Endoscopy” and “Gastroenterology” and is member of the International Editorial board of “Endoscopy” and “Gastrointestinal Endoscopy”. He has authored and co-authored on over 400 peer reviewed publications and text book chapters and has lectured at many national and international meetings.

Jacques Bergman is the head of the AMC esophageal research team. The team has three main research themes.

The endoscopic imaging research line focusses on the endoscopic detection of early neoplasia in Barrett’s esophagus including computer assisted detection. Dr Jeroen de Groof, MD PhD is the leading post-doc and there are currently 6 PhD fellows working on this project.

The Barrett’s surveillance and biomarker research line is led by Dr. Lucas Duits, MD, PhD and focusses on optimizing and reducing Barrett’s surveillance and implementing biomarker risk prediction. There are currently 4 PhD fellows working on this project.

The endoscopic treatment of upper GI neoplasia is run by Dr Roos Pouw, MD PhD. Here we investigate the optimal use of endoscopic resection and ablation for early upper GI neoplasia with a special focus on expanding endoscopic management of T1b cancers. There are currently 4 PhD fellows working on several projects.

The team closely collaborates with professor Peter de With and Dr Fons van der Sommen of the Video Coding and Architectures group of the Technical University Eindhoven, the Netherlands, Dr Matt Stachler, University of California San Franscisco, Dr Marjanka Schmidt, National Cancer Institute, AvL, the Netherlands, the Dutch Barrett Expert center Consortium, the Dutch Barrett surveillance consortium, and the BONS-AI consortium.

Jacques Bergman is also involved in studies investigating the use of duodenal mucosal ablation for metabolic regulation (diabetes mellitus and NAFLD/NASH) in which he collaborates with endocrinologists and hepatologists at the AUMC and a number of European institutes. He is the PI of six clinical trials in this field.

The esophageal research team currently consists of three interventional endoscopists, seventeen clinical research fellows, three research nurses, and 2 physician assistants.

Finally, Jacques Bergman has a strong interest in the “less-is-more in endoscopy“ concept. He is the co-chair of the Implementation Committee of the Knowledge Agenda of the Dutch Association of Gastroenterologists, which strives to reduce over-utilization in endoscopy.